Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232 [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate the safety and pharmacokinetics of AD-123 compared to coadministration of AD-1231 and AD-1232 in diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• AD-123
• AD-1231
• AD-1232

Snippet

Sponsor: Addpharma Inc. | Conditions: Diabetes Mellitus | Phase 1 | Status: NOT_YET_RECRUITING